Cargando…
Invasive Fungal Disease in Patients with Myeloid Malignancies: A Retrospective Cohort Study of a Diagnostic-Driven Care Pathway Withholding Mould-Active Prophylaxis
Objectives: Patients receiving remission induction therapy for acute myeloid leukaemia (AML) are at high risk of developing invasive fungal disease (IFD). Newer therapies with targeted antileukemic agents and the emergence of azole resistance pose a challenge to the strategy of primary antifungal pr...
Autores principales: | De Kort, Elizabeth A., Buil, Jochem B., Schalekamp, Steven, Schaefer-Prokop, Cornelia, Verweij, Paul E., Schaap, Nicolaas P. M., Blijlevens, Nicole M. A., Van der Velden, Walter J. F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504036/ https://www.ncbi.nlm.nih.gov/pubmed/36135650 http://dx.doi.org/10.3390/jof8090925 |
Ejemplares similares
-
High‐dose posaconazole for azole‐resistant aspergillosis and other difficult‐to‐treat mould infections
por: Schauwvlieghe, Alexander F. A. D., et al.
Publicado: (2019) -
Prophylaxis of mould infections
por: Moreno-García, Estela, et al.
Publicado: (2019) -
P1530: CORTICOSTEROIDS FOR INFLAMMATORY RESPONSES DURING INDUCTION CHEMOTHERAPY IN MYELOID MALIGNANCIES ARE NOT ASSOCIATED WITH INCREASED INCIDENCE OF INVASIVE FUNGAL INFECTIONS
por: Migchelbrink, Jorne, et al.
Publicado: (2023) -
Benefits of risk‐adapted and mould‐specific antifungal prophylaxis in childhood leukaemia
por: Meryk, Andreas, et al.
Publicado: (2020) -
Burden of serious fungal infections in the Netherlands
por: Buil, Jochem B., et al.
Publicado: (2020)